Job Details

As the Research Treatment Nurse for the Drug Development Unityour primary responsibility is to treat and manage patients enrolled on clinical trials. This position is based in a clinic setting outside of Presbyterian St. Luke's Medical Center.

• You will closely follow study patient(s) throughout treatment course ensuring protocol compliance

• You will administer chemotherapy as ordered by physicians

• You will read and interpret EKGs

• Must communicate all protocol related issues/problems to the investigator

• You will assess patient for side effects of treatment and symptoms related to disease or disease progression

• You will assess lab data and communicates abnormal findings to the investigator and oncologist

• You will assess and document patient compliance with medications and return visits

• You will communicate with the pharmacy staff to provide timely and accurate study drug distribution

• You will maintain a current medication list and records in protocol specific requirements

• You will provide data team with completed follow-up forms, medical records, lab data and other source documents in a timely manner

• You will educate and orient ancillary staff in study specific procedures

• You will document and report adverse events

• You will performs telephone triage

• Assesses the patients EMR to ensure that all required data has been entered prior to patients scheduled appointment

• You will perform patient counseling and referral to appropriate support services

• You will monitor schedules daily for appropriate treatment distribution and additional patient visits

You should have for this position: 

• An Associate Degree; preferably a Bachelor’s Degree

• Current licensure in the state of Colorado as a Registered Nurse 

• Knowledge of medical and research terminology

• Knowledge of FDA Code of Federal Regulations and GCP

• Knowledge of the clinical research processes

• Knowledge of Phase I protocol 

• One year of acute care nursing experience required

• At least on year of oncology experience preferred

• At least one year of experience in a research setting preferred

• Current BLS certification 

• Current ACLS certification (can complete within nine months of start date)

• ONS Chemotherapy Provider card (can complete within nine months of start date)

• Research Certification (ACRP or CCRP) Preferred

About Sarah Cannon Research Institute

Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 750 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. SCRI’s research network brings together more than 1,300 physicians who are actively enrolling patients into clinical trials at more than 250 locations in 24 states across the U.S. Please click here to learn more about our research offerings.

We care about the well-being of the patients and communities we serve, and that starts with caring for our people. That’s why we have a Total Rewards package that includes comprehensive benefits to support physical, mental, and financial well-being. Our Total Rewards offerings serve the different needs of our diverse colleague population and ensure they are the healthiest versions of themselves. For more information regarding benefits through our parent company, McKesson, please click here.

As part of Total Rewards, we are proud to offer a competitive compensation package. This is determined by several factors, including performance, experience and skills, equity, regular job market evaluations, and geographical markets. In addition to base pay, other compensation, such as an annual bonus or long-term incentive opportunities may be offered.